Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Antibody Structure01:10

Antibody Structure

60.9K
Overview
Antibodies, also known as immunoglobulins (Ig), are essential players of the adaptive immune system. These antigen-binding proteins are produced by B cells and make up 20 percent of the total blood plasma by weight. In mammals, antibodies fall into five different classes, which each elicits a different biological response upon antigen binding.
The Y-Shaped Structure of Antibodies Consists of Four Polypeptide Chains
Antibodies consist of four polypeptide chains: two identical heavy...
60.9K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Structome-TM: complementing dataset assembly for structural phylogenetics by addressing size-based biases.

Bioinformatics advances·2026
Same author

Predicting clinical efficacy of lung gene delivery in people with cystic fibrosis: which <i>in vitro</i> and <i>in vivo</i> models best predict outcomes in human lungs?

Expert opinion on drug delivery·2026
Same author

SGGly: a web server for whole-protein, structure-guided analysis of candidate N-linked glycosylation sites.

Nucleic acids research·2026
Same author

Inhalable gene and RNA therapy for cystic fibrosis: perspectives and progress in clinical development.

Nanomedicine (London, England)·2026
Same author

A three generation family with VACTERL association is found to have a rare form of diamond-blackfan anaemia.

European journal of human genetics : EJHG·2026
Same author

Transformers as a substrate for structural biology.

Current opinion in structural biology·2026
Same journal

Tracking Synthetic Adhesins on Bacterial Surfaces with Immunofluorescence Microscopy.

Methods in molecular biology (Clifton, N.J.)·2026
Same journal

Post-Selection Methods for Analyzing mRNA Display Selections and Optimization of Hits.

Methods in molecular biology (Clifton, N.J.)·2026
Same journal

High-Performance Computing in Tandem Mass Spectrometry (MS/MS) Peptide Identification.

Methods in molecular biology (Clifton, N.J.)·2026
Same journal

Engineering and Adapting Disulfide-Containing Proteins to Enable Intracellular Functionality.

Methods in molecular biology (Clifton, N.J.)·2026
Same journal

AI-Driven Protein Research: From Prediction to Design.

Methods in molecular biology (Clifton, N.J.)·2026
Same journal

Methods for the In Vitro Selection of Protein and Peptide Libraries Using mRNA Display.

Methods in molecular biology (Clifton, N.J.)·2026
See all related articles

Related Experiment Video

Updated: Aug 22, 2025

Identification of Mouse and Human Antibody Repertoires by Next-Generation Sequencing
08:51

Identification of Mouse and Human Antibody Repertoires by Next-Generation Sequencing

Published on: March 15, 2019

12.5K

Using Graph-Based Signatures to Guide Rational Antibody Engineering.

David B Ascher1,2,3,4, Lisa M Kaminskas5, Yoochan Myung1,2,4

  • 1Structural Biology and Bioinformatics, Department of Biochemistry and Molecular Biology, Bio21 Institute, University of Melbourne, Parkville, VIC, Australia.

Methods in Molecular Biology (Clifton, N.J.)
|November 8, 2022
PubMed
Summary
This summary is machine-generated.

Rational antibody engineering is enhanced by mCSM, a computational tool. This in silico suite identifies mutation consequences to improve antibody stability, affinity, and specificity for better biotherapeutics.

Keywords:
Antibody engineeringAntibody interactionsAntibody structureGraph-based signaturesMutationRational engineeringmCSMmCSM-ABmCSM-AB2mmCSM-AB

More Related Videos

Rapid Antibody Glycoengineering in Chinese Hamster Ovary Cells
06:53

Rapid Antibody Glycoengineering in Chinese Hamster Ovary Cells

Published on: June 2, 2022

3.3K
Genetic Encoding of a Non-Canonical Amino Acid for the Generation of Antibody-Drug Conjugates Through a Fast Bioorthogonal Reaction
11:02

Genetic Encoding of a Non-Canonical Amino Acid for the Generation of Antibody-Drug Conjugates Through a Fast Bioorthogonal Reaction

Published on: September 14, 2018

7.8K

Related Experiment Videos

Last Updated: Aug 22, 2025

Identification of Mouse and Human Antibody Repertoires by Next-Generation Sequencing
08:51

Identification of Mouse and Human Antibody Repertoires by Next-Generation Sequencing

Published on: March 15, 2019

12.5K
Rapid Antibody Glycoengineering in Chinese Hamster Ovary Cells
06:53

Rapid Antibody Glycoengineering in Chinese Hamster Ovary Cells

Published on: June 2, 2022

3.3K
Genetic Encoding of a Non-Canonical Amino Acid for the Generation of Antibody-Drug Conjugates Through a Fast Bioorthogonal Reaction
11:02

Genetic Encoding of a Non-Canonical Amino Acid for the Generation of Antibody-Drug Conjugates Through a Fast Bioorthogonal Reaction

Published on: September 14, 2018

7.8K

Area of Science:

  • Biochemistry
  • Computational Biology
  • Immunology

Background:

  • Antibodies are crucial tools in research, diagnostics, and therapy.
  • Biotherapeutics, particularly antibodies, have revolutionized disease treatment.
  • Advances in computational methods enable rational protein engineering.

Purpose of the Study:

  • To describe the application of the mCSM web-based suite for antibody engineering.
  • To demonstrate how in silico analysis can guide the rational design of antibodies.
  • To improve antibody stability, affinity, and specificity through computational guidance.

Main Methods:

  • Utilized the mCSM web-based in silico suite.
  • Employed graph-based signatures to analyze mutation effects.
  • Applied computational predictions to guide antibody engineering.

Main Results:

  • mCSM rapidly identified structural and functional consequences of mutations.
  • The tool guided rational engineering efforts.
  • Improvements in antibody stability, affinity, and specificity were achieved.

Conclusions:

  • The mCSM suite is a valuable tool for rational antibody engineering.
  • Computational approaches significantly enhance the design of improved antibody therapeutics.
  • This method offers a pathway to develop antibodies with superior properties.